the cause of fever after platelet transfusion?

The level of CD40 ligand in stored platelet concentrates is similar to human blood levels during inflammation and may explain febrile responses to transfusions.

By | June 22, 2001

Febrile responses to platelet transfusions are common but some can be life-threatening and the cause of these reactions is largely unknown. In June 23 Lancet, Richard Phipps and colleagues from University of Rochester Cancer Center, Rochester, New York, suggest that these febrile responses could be due to the release of CD40 ligand from the platelets.

Human platelets contain preformed CD40 ligand that can be expelled after activation to initiate the wound healing process. The CD40 ligand is associated with the production of proinflammatory prostaglandin E2 (PGE2), the key inducer of fever in man.

Phipps et al. randomly assessed 9 preparations of platelets due for transfusion and found that the amounts of CD40 ligand (3000 ng/L to more than 7000 ng/L) was similar to concentrations found in human blood during chronic inflammation (Lancet 2001, 357:2023-2024).

They speculate that keeping the release of CD40 ligand to a minimum, or removing free CD40 ligand before transfusion, might effectively reduce adverse events following platelet transfusions. In addition, individuals whose platelets are especially rich in CD40 ligand might be excluded as donors for transfusions.

Advertisement

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Mettler Toledo
Mettler Toledo
Advertisement
Life Technologies